These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8996451)

  • 21. Pertussis immunization.
    Simon FA
    Pediatrics; 1979 Sep; 64(3):387-8. PubMed ID: 481986
    [No Abstract]   [Full Text] [Related]  

  • 22. Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial.
    Taranger J; Trollfors B; Knutsson N
    Dev Biol Stand; 1997; 89():109-12. PubMed ID: 9272340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An approach to the evaluation of the efficacy of anti-pertussis vaccination].
    Barlassina C; Silvestri MG; Ariano E
    Clin Ter; 1987 Aug; 122(4):245-9. PubMed ID: 2973384
    [No Abstract]   [Full Text] [Related]  

  • 24. Why pertussis immunisation?
    Tribe P
    Aust Fam Physician; 1989 Aug; 18(8):985-90. PubMed ID: 2673176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
    Liese JG; Stojanov S; Belohradsky BH
    Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against pertussis with a monocomponent pertussis toxoid vaccine.
    Taranger J; Trollfors B; Lagergârd T; Robbins JB
    Biologicals; 1999 Jun; 27(2):89. PubMed ID: 10600190
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.
    Halperin SA; Eastwood B; Barreto L; Mills E; Blatter M; Reisinger K; Bader G; Keyserling H; Roberts EA; Guasparini R
    Scand J Infect Dis; 1995; 27(3):279-87. PubMed ID: 8539554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pertussis and the pertussis vaccine.
    McKercher SW
    S D J Med; 1986 Jan; 39(1):5-11. PubMed ID: 3484836
    [No Abstract]   [Full Text] [Related]  

  • 29. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
    N Y State J Med; 1982 Oct; 82(11):1563-9. PubMed ID: 6959004
    [No Abstract]   [Full Text] [Related]  

  • 30. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.
    Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B
    Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):896-905. PubMed ID: 2998252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of pertussis and high expectations concerning vaccines].
    Wysocki J
    Przegl Epidemiol; 2004; 58 Suppl 1():39-43. PubMed ID: 15807156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Present and future of oral pertussis vaccination].
    Falk W; Höfler KH; Rosanelli K; Kurz R
    Fortschr Med; 1981 Sep; 99(34):1363-6. PubMed ID: 6116657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against pertussis.
    Evans DG
    Mem Acad R Med Belg; 1972 Mar; 7(6):447-53. PubMed ID: 4339774
    [No Abstract]   [Full Text] [Related]  

  • 36. [Efficacy of acellular pertussis vaccines].
    Wirsing von König CH; Finger H
    Immun Infekt; 1995 Aug; 23(4):125-9. PubMed ID: 7558115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Whooping cough and whooping cough vaccination - a dilemma of the vaccination policy].
    Taranger J
    Lakartidningen; 1982 May; 79(19):1935-8. PubMed ID: 7132489
    [No Abstract]   [Full Text] [Related]  

  • 38. Neurologic manifestations of diphtheria and pertussis.
    Sanghi V
    Handb Clin Neurol; 2014; 121():1355-9. PubMed ID: 24365424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP.
    Robbins JB; Schneerson R; Keith JM; Shiloach J; Miller M; Trollors B
    Vaccine; 2007 Apr; 25(15):2811-6. PubMed ID: 17291636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets.
    Polewicz M; Gracia A; Buchanan R; Strom S; Halperin SA; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Oct; 29(44):7718-26. PubMed ID: 21856353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.